CPT code 95930 is the Current Procedural Terminology designation for visual evoked potential (VEP) testing, a diagnostic neurophysiology procedure that records the brain’s electrical response to visual stimuli and includes interpretation and report. The code is used nationally to document objective visual pathway assessment for conditions affecting the optic nerve and visual cortex, excluding glaucoma-specific VEP applications. Its inclusion of interpretation and reporting affects billing workflows and bundling rules.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical sites of service, an outline of common modifiers and billing considerations, and an explanation of what is and is not included in the CPT code description. The publication highlights national implications for claims processing and coding compliance, as well as practical points about where the service is typically performed—outpatient hospital clinics, ambulatory neurodiagnostic labs, and neurology specialty settings.

This coverage is intended to orient clinicians, coding staff, and policy stakeholders to the code’s clinical purpose, reporting scope, and payer relevance. Data not available in the input will be noted where applicable.